EHC

In the past six months, Encompass Health's stock has been influenced by several key events, including strong first-quarter 2026 financial performance, leading to raised full-year guidance. The company continued its share repurchase program and declared a quarterly dividend. Encompass Health expanded its capacity by opening a new rehabilitation hospital in Pennsylvania. Barclays lowered its price target on Encompass Health, while maintaining an "Overweight" rating. Over the last 12 months, the stock's price has decreased, though it has seen a year-to-date return and a slight increase in the past month.